tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kiniksa Pharmaceuticals: Strong Buy Rating Driven by Arcalyst’s Market Success and Promising Pipeline
PremiumRatingsKiniksa Pharmaceuticals: Strong Buy Rating Driven by Arcalyst’s Market Success and Promising Pipeline
25d ago
Kiniksa initiated with a Buy at TD Cowen
Premium
The Fly
Kiniksa initiated with a Buy at TD Cowen
25d ago
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth
Premium
Company Announcements
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth
2M ago
Kiniksa raises FY25 ARCALYST revenue view to $625M-$640M from $590M-$605M
PremiumThe FlyKiniksa raises FY25 ARCALYST revenue view to $625M-$640M from $590M-$605M
3M ago
KNSA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KNSA Earnings this Week: How Will it Perform?
3M ago
Kiniksa price target raised to $42 from $30 at Wells Fargo
Premium
The Fly
Kiniksa price target raised to $42 from $30 at Wells Fargo
4M ago
Kiniksa announces Carly Pearce joined the Life DisRPted Campaign
PremiumThe FlyKiniksa announces Carly Pearce joined the Life DisRPted Campaign
6M ago
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
6M ago
Kiniksa price target raised to $45 from $40 at Jefferies
Premium
The Fly
Kiniksa price target raised to $45 from $40 at Jefferies
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100